ICU Medical (NASDAQ:ICUI) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a report published on Saturday.

ICUI has been the topic of several other research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a report on Thursday, January 22nd. Piper Sandler boosted their target price on ICU Medical from $153.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Finally, KeyCorp upped their target price on ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus target price of $175.67.

ICU Medical Stock Performance

Shares of ICUI opened at $151.86 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.45 and a quick ratio of 1.19. The firm’s 50 day moving average is $148.71 and its 200-day moving average is $134.66. ICU Medical has a 12-month low of $107.00 and a 12-month high of $165.17. The stock has a market capitalization of $3.75 billion, a P/E ratio of -489.86 and a beta of 0.79.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Cullen Frost Bankers Inc. purchased a new position in ICU Medical during the 2nd quarter valued at about $38,000. SJS Investment Consulting Inc. lifted its position in shares of ICU Medical by 41,000.0% in the third quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock worth $49,000 after purchasing an additional 410 shares in the last quarter. Covestor Ltd boosted its holdings in shares of ICU Medical by 70.7% during the third quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock worth $68,000 after purchasing an additional 236 shares during the period. Strs Ohio grew its position in ICU Medical by 60.0% during the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock valued at $114,000 after purchasing an additional 300 shares in the last quarter. Finally, Blue Trust Inc. grew its position in ICU Medical by 17.6% during the second quarter. Blue Trust Inc. now owns 942 shares of the medical instruments supplier’s stock valued at $124,000 after purchasing an additional 141 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.